Latest filing published 17 Jan 2018 for Ensysce Biosciences, Inc..
No signal scores available.
This profile gathers the share dealings of George Peng in Ensysce Biosciences, Inc. Over a trading history stretching from 5 December 2017 to 15 January 2018, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 17 January 2018, the filings show a transaction in Ensysce Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations